Experience with californium 252 in clinical radiotherapy.
D000368:Aged; D002142:Californium / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000532:radiotherapy*; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D002610:Cheek; D003201:Computers; D005069:Evaluation Studies as Topic; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D008048:Lip Neoplasms / Q000532:radiotherapy; D008175:Lung Neoplasms / Q000532:radiotherapy; D008297:Male; D008545:Melanoma / Q000532:radiotherapy*; D008722:Methods; D009369:Neoplasms / Q000532:radiotherapy*; D010865:Pilot Projects; D011482:Protective Devices; D011835:Radiation Protection; D011879:Radiotherapy Dosage; D011883:Radium / Q000627:therapeutic use; D013997:Time Factors; D014062:Tongue Neoplasms / Q000532:radiotherapy; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy; D014625:Vaginal Neoplasms / Q000532:radiotherapy
D002142:Californium; D011883:Radium